Impaired lipid and glucose homeostasis in hexabromocyclododecane- exposed mice fed a high-fat diet

Environmental Health Perspectives

Volumn 122, Issue 3, 2014, Pages 277-283

  Yanagisawa, Rie ^a   Koike, Eiko ^a   Win Shwe, Tin Tin ^a   Yamamoto, Megumi ^b   Takano, Hirohisa ^c  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b NATIONAL INSTITUTE FOR MINAMATA DISEASE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; HEXABROMOCYCLODODECANE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; INSULIN BLOOD LEVEL; INSULIN TOLERANCE TEST; LIPID DIET; LIPID METABOLISM; LIVER WEIGHT; MACROPHAGE; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEATOSIS; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FLAME RETARDANTS; HOMEOSTASIS; HYDROCARBONS, BROMINATED; LIPID METABOLISM; LIVER; MALE; METABOLIC DISEASES; MICE; MICE, INBRED C57BL; OBESITY; POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84895148860     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1307421     Document Type: Article

References (56)

1. Airaksinen R, Rantakokko P, Eriksson J, Blomstedt P, Kajantie E, Kiviranta H. 2011. Association between type 2 diabetes and exposure to persistent organic pollutants. Diabetes Care 34(9):1972-1979.
2. Arsenescu V, Arsenescu RI, King V, Swanson H, Cassis LA. 2008. Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ Health Perspect 116:761-768; doi:10.1289/ehp.10554.
3. Baillie-Hamilton P. 2002. Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 8(2):185-192.
4. Bradbury MW. 2006. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol 290(2):G194-G198.
5. Cantón R, Peijnenburg AACM, Hoogenboom RLAP, Piersma A, van der Ven LTM, van den Berg M, et al. 2008. Subacute effects of hexabromocyclododecane (HBCD) on hepatic gene expression profiles in rats. Toxicol Appl Pharmacol 231(2):267-272.
6. Carvalho E, Kotani K, Peroni O, Kahn B. 2005. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am J Physiol Endocrinol Metab 289(4):E551-E561.
7. Covaci A, Gerecke A, Law R, Voorspoels S, Kohler M, Heeb N, et al. 2006. Hexabromocyclododecanes (HBCDs) in the environment and humans: a review. Environ Sci Technol 40(12):3679-3688.
8. Covaci A, Voorspoels S, Roosens L, Jacobs W, Blust R, Neels H. 2008. Polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) in human liver and adipose tissue samples from Belgium. Chemosphere 73(2):170-175.
9. de Wit C. 2002. An overview of brominated flame retardants in the environment. Chemosphere 46(5):583-624.
10. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. 1993. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268(16):11811-11816.
11. Eriksson P, Fischer C, Wallin M, Jakobsson E, Fredriksson A. 2006. Impaired behaviour, learning and memory, in adult mice neonatally exposed to hexabromocyclododecane (HBCDD). Environ Toxicol Pharmacol 21(3):317-322.
12. Fängström B, Athanassiadis I, Odsjö T, Norén K, Bergman A. 2008. Temporal trends of polybrominated diphenyl ethers and hexabromocyclododecane in milk from Stockholm mothers, 1980-2004. Mol Nutr Food Res 52(2):187-193.
13. Food Standards Agency. 2006. Brominated Chemicals: UK Dietary Intakes. Food Survey Information Sheet 10/06. London:Food Standards Agency. Available: http://multimedia.food.gov.uk/multimedia/pdfs/fsis1006.pdf [accessed 10 February 2014].
14. Garvey WT, Maianu L, Zhu JH, Brechtel Hook G, Wallace P, Baron AD. 1998. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 101(11):2377-2386.
15. Germer S, Piersma AH, van der Ven L, Kamyschnikow A, Fery Y, Schmitz HJ, et al. 2006. Subacute effects of the brominated flame retardants hexabromocyclododecane and tetrabromobisphenol A on hepatic cytochrome P450 levels in rats. Toxicology 218(2-3):229-236.
16. Greco D, Kotronen A, Westerbacka J, Puig O, Arkkila P, Kiviluoto T, et al. 2008. Gene expression in human NAFLD. Am J Physiol Gastrointest Liver Physiol 294(5):G1281-G1287.
17. Grün F, Blumberg B. 2007. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord 8(2):161-171.
18. Grundy SM. 2004. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89(6):2595-2600.
19. Ha MH, Lee DH, Jacobs D. 2007. Association between serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence: results from the National Health and Nutrition Examination Survey, 1999-2002. Environ Health Perspect 115:1204-1209; doi:10.1289/ehp.10184.
20. Harrad S, de Wit C, Abdallah M, Bergh C, Björklund J, Covaci A, et al. 2010. Indoor contamination with hexabromocyclododecanes, polybrominated diphenyl ethers, and perfluoroalkyl compounds: an important exposure pathway for people? Environ Sci Technol 44(9):3221-3231.
21. Hotamisligil GS. 2006. Inflammation and metabolic disorders. Nature 444(7121):860-867.
22. Hrnciar J, Gábor D, Hrnciarová M, Okapcová J, Szentiványi M, Kurray P. 1999. Relation between cytokines (TNF-alpha, IL-1 and 6) and homocysteine in android obesity and the phenomenon of insulin resistance syndromes [in Slovak]. Vnitr Lek 45(1):11-16.
23. Inoue M, Ohtake T, Motomura W, Takahashi N, Hosoki Y, Miyoshi S, et al. 2005. Increased expression of PPARγ in high fat diet-induced liver steatosis in mice. Biochem Biophys Res Commun 336(1):215-222.
24. Janák K, Covaci A, Voorspoels S, Becher G. 2005. Hexabromocyclododecane in marine species from the Western Scheldt Estuary: diastereoisomer-and enantiomer-specific accumulation. Environ Sci Technol 39(7):1987-1994.
25. Janesick A, Blumberg B. 2011. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today 93(1): 34-50.
26. Jones KC, de Voogt P. 1999. Persistent organic pollutants (POPs): state of the science. Environ Pollut 100(1-3):209-221.
27. Kahn BB, Flier JS. 2000. Obesity and insulin resistance. J Clin Invest 106(4):473-481.
28. Koike E, Yanagisawa R, Takigami H, Takano H. 2012. Brominated flame retardants stimulate mouse immune cells in vitro. J Appl Toxicol 33(12):1451-1459.
29. Lee DH, Lind L, Jacobs DR Jr, Salihovic S, van Bavel B, Lind PM. 2012. Associations of persistent organic pollutants with abdominal obesity in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Environ Int 40:170-178.
30. Leguisamo NM, Lehnen AM, Machado UF, Okamoto MM, Markoski MM, Pinto GH, et al. 2012. GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome. Cardiovasc Diabetol 11:100; doi:10.1186/1475-2840-11-100.
31. Lind Y, Darnerud PO, Aune M, Becker W. 2002. Exponering för organiska miljökontaminanter via livsmedel [in Swedish]. Uppsala:Swedish National Food Administration (Livsmedelsverket).
32. Malarvannan G, Dirinck E, Dirtu A, Pereira Fernandes A, Neels H, Jorens P, et al. 2013. Distribution of persistent organic pollutants in two different fat compartments from obese individuals. Environ Int 55:33-42.
33. Matsusue K, Kusakabe T, Noguchi T, Takiguchi S, Suzuki T, Yamano S, et al. 2008. Hepatic steatosis in leptin-deficient mice is promoted by the PPARγ target gene Fsp27. Cell Metab 7(4):302-311.
34. Newbold R. 2010. Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones 9(3):206-217.
35. Ogden C, Flegal K, Carroll M, Johnson C. 2002. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288(14):1728-1732.
36. Ouchi N, Parker JL, Lugus JJ, Walsh K. 2011. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11(2):85-97.
37. Roosens L, Abdallah MA, Harrad S, Neels H, Covaci A. 2009. Exposure to hexabromocyclododecanes (HBCDs) via dust ingestion, but not diet, correlates with concentrations in human serum: preliminary results. Environ Health Perspect 117:1707-1712; doi:10.1289/ ehp.0900869.
38. Rotter V, Nagaev I, Smith U. 2003. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278(46):45777-45784.
39. Ruzzin J, Petersen R, Meugnier E, Madsen L, Lock EJ, Lillefosse H, et al. 2010. Persistent organic pollutant exposure leads to insulin resistance syndrome. Environ Health Perspect 118:465-471; doi:10.1289/ehp.0901321.
40. Saito I, Onuki A, Yaguchi K, Ogata A. 2008. Summary of indoor air pollution by plasticizers, flame retardants, and pesticides followed by an estimation of inhalation exposure in Tokyo [in Japanese]. Ann Rep Tokyo Metr Inst Public Health 59:27-38.
41. Schadinger SE, Bucher NL, Schreiber BM, Farmer SR. 2005. PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am J Physiol Endocrinol Metab 288(6):E1195-E1205.
42. Semple RK, Chatterjee VK, O'Rahilly S. 2006. PPARγ and human metabolic disease. J Clin Invest 116(3):581-589.
43. Shang J, Chen Ll, Xiao FX, Sun H, Ding HC, Xiao H. 2008. Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase. Acta Pharmacol Sin 29(6):698-706.
44. Shearer J, Fueger PT, Bracy DP, Wasserman DH, Rottman JN. 2005. Partial gene deletion of heart-type fatty acid-binding protein limits the severity of dietary-induced insulin resistance. Diabetes 54(11):3133-3139.
45. Stockholm Convention. 2010. Stockholm Convention on Persistent Organic Pollutants Homepage. Available: http://chm.pops.int/Home/tabid/2121/mctl/ViewDetails/EventModID/871/EventID/407/xmid/6921/Default.aspx [accessed 18 July 2013].
46. Suganami T, Nishida J, Ogawa Y. 2005. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α. Arterioscler Thromb Vasc Biol 25(10):2062-2068.
47. Tan X, Xie G, Sun X, Li Q, Zhong W, Qiao P, et al. 2013. High fat diet feeding exaggerates perfluorooctanoic acid-induced liver injury in mice via modulating multiple metabolic pathways. PLoS One 8(4):e61409; doi:10.1371/journal.pone.0061409.
48. Uemura H, Arisawa K, Hiyoshi M, Kitayama A, Takami H, Sawachika F, et al. 2009. Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan's general population. Environ Health Perspect 117:568-573; doi:10.1289/ehp.0800012.
49. van der Ven LT, Verhoef A, van de Kuil T, Slob W, Leonards PE, Visser TJ, et al. 2006. A 28-day oral dose toxicity study enhanced to detect endocrine effects of hexabromocyclododecane in Wistar rats. Toxicol Sci 94(2):281-292.
50. Wahlang B, Falkner KC, Gregory B, Ansert D, Young D, Conklin DJ, et al. 2013. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice. J Nutr Biochem 24(9):1587-1595.
51. Wan Y, Saghatelian A, Chong LW, Zhang CL, Cravatt B, Evans RM. 2007. Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milk. Genes Dev 21(15):1895-1908.
52. Watson R, Kanzaki M, Pessin J. 2004. Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 25(2):177-204.
53. Weiss J, Wallin E, Axmon A, Jönsson BA, Akesson H, Janák K, et al. 2006. Hydroxy-PCBs, PBDEs, and HBCDDs in serum from an elderly population of Swedish fishermen's wives and associations with bone density. Environ Sci Technol 40(20):6282-6289.
54. Xian Q, Ramu K, Isobe T, Sudaryanto A, Liu X, Gao Z, et al. 2008. Levels and body distribution of polybrominated diphenyl ethers (PBDEs) and hexabromocyclododecanes (HBCDs) in freshwater fishes from the Yangtze River, China. Chemosphere 71(2):268-276.
55. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112(12):1821-1830.
56. Yu MH. 2000. Factors affecting xenobiotic action. In: Environmental Toxicology: Impacts of Environmental Toxicants on Living Systems. Boca Raton, FL:CRC Press, 47-64.